The Syneos Health Podcast
152 Episoder
-
Payer Power, Part 3
Publisert: 15.7.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 12: COVID-19 and Children
Publisert: 19.6.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 11: Rare Disease Clinical Trials and COVID-19
Publisert: 2.6.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Yelp Ratings for Clinical Trials
Publisert: 27.5.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
Publisert: 15.5.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Real World Data for Clinical Innovation
Publisert: 8.5.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 10: Ventilating the COVID-19 Patient
Publisert: 5.5.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 9: Telemedicine in the Age of COVID-19
Publisert: 23.4.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 8: Payers and COVID-19
Publisert: 16.4.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 7: Continuity in Clinical Trials
Publisert: 2.4.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Publisert: 30.3.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 5: Surviving the Ventilator Shortage
Publisert: 24.3.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 4: Clinical Trials Through Pandemics
Publisert: 24.3.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 3: Virtual Clinical Trials
Publisert: 20.3.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 2: The Clinical Experience
Publisert: 17.3.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 1: The Personal Experience
Publisert: 13.3.2020 -
Recruiting Patients for Clinical Trials
Publisert: 6.3.2020 -
Medical Affairs Series, Part Six: Commercial Plus Medical Affairs
Publisert: 19.2.2020 -
2020 Health Trends: Box Store Healthcare
Publisert: 5.2.2020 -
Denials, Delays and Deep Discounts in Pharmaceutical Launch
Publisert: 24.1.2020
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.